LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Long Term Debt Summary of LegoChem Biosciences, Inc.

  • LegoChem Biosciences, Inc.'s latest annual long term debt in 2023 was 528.37 Million KRW , up 144.16% from previous year.
  • LegoChem Biosciences, Inc.'s latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
  • LegoChem Biosciences, Inc. reported annual long term debt of 216.4 Million KRW in 2022, down -97.63% from previous year.
  • LegoChem Biosciences, Inc. reported annual long term debt of 9.14 Billion KRW in 2021, up 153.24% from previous year.
  • LegoChem Biosciences, Inc. reported quarterly long term debt of 128.67 Million KRW for 2024 Q1, down 0.0% from previous quarter.
  • LegoChem Biosciences, Inc. reported quarterly long term debt of 174.6 Million KRW for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Long Term Debt of LegoChem Biosciences, Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 528.37 Million KRW 144.16%
2022 216.4 Million KRW -97.63%
2021 9.14 Billion KRW 153.24%
2020 3.61 Billion KRW 90.11%
2019 1.9 Billion KRW 0.0%
2018 - KRW -100.0%
2017 8.51 Billion KRW 8.48%
2016 7.85 Billion KRW 0.0%

Peer Long Term Debt Comparison of LegoChem Biosciences, Inc.

Name Long Term Debt Long Term Debt Difference
HLB Co., Ltd. 17.93 Billion KRW 97.054%
iNtRON Biotechnology, Inc. 258.29 Million KRW -104.562%
BINEX Co., Ltd. 5.57 Billion KRW 90.528%
Bioneer Corporation 12.5 Billion KRW 95.773%
Anterogen.Co.,Ltd. - KRW -Infinity%
MEDIPOST Co., Ltd. 6.99 Billion KRW 92.446%
CrystalGenomics, Inc. 29.88 Billion USD 98.232%
Helixmith Co., Ltd 151.68 Million KRW -248.347%
Chabiotech Co.,Ltd. 95.06 Billion KRW 99.444%
Medy-Tox Inc. 1.22 Billion KRW 56.897%
Peptron, Inc. 4.5 Billion KRW 88.258%
Amicogen, Inc. 70.65 Billion KRW 99.252%
Genexine, Inc. 22.68 Billion KRW 97.67%
HLB Therapeutics Co.,Ltd. 1.84 Billion KRW 71.287%
ALTEOGEN Inc. 1.24 Billion KRW 57.705%
PharmaResearch Co., Ltd. 970.71 Million KRW 45.569%
SillaJen, Inc. 8.13 Billion KRW 93.506%
JETEMA, Co., Ltd. 60 Billion KRW 99.119%
OliX Pharmaceuticals,Inc 35.36 Billion KRW 98.506%
Genomictree Inc. 97.51 Million KRW -441.834%
MedPacto, Inc. 1.68 Billion KRW 68.679%
D&D Pharmatech 5.12 Billion KRW 89.681%
EASY BIO,Inc. 30 Billion KRW 98.239%
GI Innovation, Inc. 2.9 Billion KRW 81.805%